Skip to main content

Table 3 Symptoms and treatments in the year after PICU discharge in 39 children by ARDS type

From: Whole pulmonary assessment 1 year after paediatric acute respiratory distress syndrome: prospective multicentre study

 

p-ARDS n = 31

ep-ARDS n = 8

p value

Time after discharge (year)

1.06 (1–1.11)

1.05 (0.94–1.11)

0.75

Respiratory symptoms at rest, exercise, maintenance treatment

23 (74.2%)

1 (12.5%)

0.0026

Chronic cough

5 (16.1%)

0

0.56

Wheezing episodes

16 (51.6%)

0

0.012

 A least 3 wheezing episodes

10 (32.3%)

0

NA

Lower respiratory tract infection

11 (35.5%)

0

0.078

 A least 3 episodes

3 (9.7%)

0

NA

Maintenance respiratory treatment

19 (63.3%)

0

0.003

 Inhaled glucocorticosteroids

16 (51.6%)

0

0.012

 Inhaled long-acting β2-agonists

7 (22.6%)

0

0.31

 Inhaled rapid-acting β2-agonists

14 (45.2%)

0

0.034

 Inhaled rapid-acting atropinic

1 (3.2%)

0

NA

 Leukotriene modifier

2 (6.5%)

0

NA

 Oxygen therapy

1 (3.2%)

0

NA

 Course of systemic glucocorticosteroids in the year

4 (12.9%)

0

NA

 Antibiotics

9 (29.0%)

0

0.16

  1. ep-ARDS extra-pulmonary ARDS, p-ARDS pulmonary ARDS. Results are medians (interquartile ranges) for quantitative variables, and frequencies and percentages for categorical variables